Clinical Trial Update: L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating L-Serine supplementation for hereditary sensory and autonomic neuropathy type I has completed Phase 1 and Phase 2 with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Sensory and Autonomic Neuropathy Type

Drugs mentioned

• L-serine (L-serine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hereditary Sensory and Autonomic Neuropathy Type I | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-12